<DOC>
	<DOC>NCT01113580</DOC>
	<brief_summary>The purpose of this study is to determine whether the 2010/2011 Formulation Enzira vaccine is safe and elicits an immune response to seasonal influenza in healthy adults.</brief_summary>
	<brief_title>A Clinical Trial of CSL's 2010/2011 Formulation of EnziraÂ® in a Healthy Adult Population</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>Male or female aged 18 years and older at the time of the first study vaccination. Known hypersensitivity to a previous dose of influenza virus vaccine or allergy to eggs, chicken protein, neomycin, polymyxin, or any components of the Study Vaccine. Clinical signs of an active infection Vaccination with a seasonal or experimental influenza virus vaccine in the 6 months preceding study entry Females who are pregnant or lactating</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>